Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 2021 following reports of unusual thrombosis after ChAdOx1 nCoV‐19, (AstraZeneca) vaccination. Following the recognition of this syndrome, multiple consensus guidelines have been released to risk strati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavin, Michelle, Elder, Patrick T., O’Keeffe, Denis, Enright, Helen, Ryan, Eileen, Kelly, Anna, El Hassadi, Ezzat, McNicholl, Feargal P., Benson, Gary, Le, Giao N., Byrne, Mary, Ryan, Kevin, O’Connell, Niamh M., O’Donnell, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444927/
https://www.ncbi.nlm.nih.gov/pubmed/34159588
http://dx.doi.org/10.1111/bjh.17613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444927/
https://www.ncbi.nlm.nih.gov/pubmed/34159588
http://dx.doi.org/10.1111/bjh.17613

Ejemplares similares